uniQure (QURE) Enterprise Value (2015 - 2026)
uniQure's (QURE) quarterly Enterprise Value came in at -$586.6 million in Q1 2026, down 43.41% year-on-year from -$1.0 billion in Q1 2025, and up 5.78% quarter-over-quarter from -$622.5 million in Q4 2025.
uniQure (QURE) Enterprise Value (2015 - 2026) Analysis & Trends
uniQure's Enterprise Value history runs 12 years deep, the most recent figure standing at -$586.6 million for Q1 2026.
- On a quarterly basis, Enterprise Value fell 43.41% year-over-year to -$586.6 million in Q1 2026; TTM through Mar 2026 was -$586.6 million, a 43.41% decrease from a year earlier, with the FY2025 full-year figure at -$622.5 million, down 69.39% from the prior year.
- Enterprise Value advanced to -$586.6 million in Q1 2026 per QURE's latest filing, from -$622.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$315.3 million in Q1 2023 and bottomed at -$694.2 million in Q3 2025.
- The 5-year median for Enterprise Value is -$524.4 million (2024), against an average of -$506.6 million.
- Across the five-year window, Enterprise Value tumbled 101.25% in 2022 and surged 40.52% in 2024, its largest moves.
- Year by year, Enterprise Value stood at -$352.8 million in 2022, then sank by 75.12% to -$617.9 million in 2023, then jumped by 40.52% to -$367.5 million in 2024, then slumped by 69.39% to -$622.5 million in 2025, then gained by 5.78% to -$586.6 million in 2026.
- Per Business Quant, the three latest QURE Enterprise Value figures stand at -$586.6 million (Q1 2026), -$622.5 million (Q4 2025), and -$694.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | -586.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -586.55 Mn |
| Dec 31, 2025 | -622.54 Mn |
| Sep 30, 2025 | -694.25 Mn |
| Jun 30, 2025 | -376.97 Mn |
| Mar 31, 2025 | -409.01 Mn |
| Dec 31, 2024 | -367.52 Mn |
| Sep 30, 2024 | -435.24 Mn |
| Jun 30, 2024 | -524.43 Mn |
| Mar 31, 2024 | -555.68 Mn |
| Dec 31, 2023 | -617.89 Mn |
| Sep 30, 2023 | -658.91 Mn |
| Jun 30, 2023 | -628.59 Mn |
| Mar 31, 2023 | -315.34 Mn |
| Dec 31, 2022 | -352.84 Mn |
| Sep 30, 2022 | -440.31 Mn |
| Jun 30, 2022 | -500.52 Mn |
| Mar 31, 2022 | -524.89 Mn |
| Dec 31, 2021 | -556.26 Mn |
| Sep 30, 2021 | -578.46 Mn |
| Jun 30, 2021 | -677.33 Mn |